Skip to content

Effects of Resveratrol Supplementation on Inflammation and Oxidative Stress

Effects of Resveratrol Supplementation on Oxidative Stress and Inflammation in Male Professional Basketball Players

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201204212394N8
Enrollment
24
Registered
2012-05-22
Start date
2012-04-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

athlete. Routine general health check-up of sports teams

Interventions

Intervention 1: for intervention group: resveratrol supplement,200 mg capsul,one capsul per day for 6 months. Intervention 2: placebo contains Starch flour,one capsul per day for 6 months.
Prevention
Placebo
for intervention group: resveratrol supplement,200 mg capsul,one capsul per day for 6 months
placebo contains Starch flour,one capsul per day for 6 months

Sponsors

Vice-chancellor for research, Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
17 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:1.Lack of sensitivity to Resveratrol; 2.Age 17-35 years; 3.Failure to take of multivitamin - mineral and omega - 3 supplements two weeks before the intervention; 4.No smoking; 5.Failure to take of anti-inflammatory drugs; 6.Not affected by the renal, hepatic, thyroid and hemolytic anemia disease; 7.Not affected by the skeleto-musclar disorder ; Exclusion criteria: 1.Change in diet or physical activity patterns for any reason; 2.Compliance rate of less than 80; 3.Being infected with any disease;

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Tumor necrosis factor-a. Timepoint: Before intervention and 6 month after intervention. Method of measurement: ELISA; pg/ml.;Interleukin -6. Timepoint: Before intervention and 6 month after intervention. Method of measurement: ELISA; pg/ml.;F2 isoprostane. Timepoint: Before intervention and 6 month after intervention. Method of measurement: ELISA; pg/ml.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHoda Sadat Zahedi

School of Public Health, Tehran University of Medical Sciences

hoda.s.zahedi@gmail.com+98 21 8877 9118

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026